Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1573-2025

Abbott Diagnostics Scarborough, Inc. recalls Brand Name: ID NOW RSV 24T Product Name: ID NOW RSV 24T Model/Catalog Number: 435-000 S…

Abbott Diagnostics Scarborough, Inc.Scarborough, ME, United StatesReported Apr 23, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

The impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Brand Name: ID NOW RSV 24T Product Name: ID NOW RSV 24T Model/Catalog Number: 435-000 Software Version: N/A Product Description: Respiratory virus panel nucleic acid assay system Component: No

Lot / code information

Model
435-000; GTIN/DI 10811877010521
Lot #
000M906790
Model
435-000; GTIN/DI 10811877010521
Lot #
000M907271
Model
435-000; GTIN/DI 10811877010521
Lot #
000M923531
Model
435-000; GTIN/DI 10811877010521
Lot #
000M923879
Model
435-000; GTIN/DI 10811877010521
Lot #
000M924414
Show 8 more code fields
Model
435-000; GTIN/DI 10811877010521
Lot #
000M924430
Model
435-000; GTIN/DI 10811877010521
Lot #
000M926642
Model
435-000; GTIN/DI 10811877010521
Lot #
000M926679
Model
435-000; GTIN/DI 10811877010521
Lot #
000M927161

What the firm is doing

On March 4, 2025 FIELD CORRECTION NOTICE letters were sent to end user customers. Please complete the following actions, as applicable. 1. If you have impacted inventory in stock, then: " Discontinue use of and destroy any remaining inventory of the impacted lots according to your procedures. " Complete and return the Customer Reply Form (Form must be completed, signed and returned to receive a replacement lot). " Please retain this letter for your records. 2. If you have forwarded the product listed above to others in your network, then: - Inform them of this Field Correction Notice, provide to them a copy of this notice and request they take the necessary action. 3. If you do not have impacted inventory in stock, then: - All product lots not identified in Appendix I can continue to be used. If you have questions regarding this information, please contact Sedgwick by phone at 888 671 8858 (available 8am 5pm EST, Monday - Friday). Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online (http://www.fda.gov/MedWatch/report.htm), by mail (http://www.fda.gov/MedWatch/getforms.htm), by phone (1-800-332-1088), or by fax (1-800-FDA-0178). If you have experienced any patient or user injury associated with this Field Correction Notice, please immediately report the event to your local area Customer Service. ****Update added 5/8/2025**** On April 29, 2025 FIELD CORRECTION NOTICE letters were sent to customers informing them of additional lots included in this recall.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of Australia; Austria; Belgium; Bulgaria; Canada; Costa Rica; France; French Polynesia; Germany; Italy; Luxembourg; Malaysia; Netherlands; Paraguay; Poland; Qatar; Saudi Arabia; Slovenia; South Korea; Spain; Switzerland; Taiwan; United Kingdom; Uruguay.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls